Investigation into the Effectiveness of Allograft Immunocomplex Capture Fluorescence Analysis

Investigation into the Effectiveness of Allograft Immunocomplex Capture Fluorescence Analysis - Graft ICFA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023787

Enrollment

200

Registered

2016-10-01

Start date

2016-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transplantation Recipients

Interventions

Graft ICFA is performed when a graft (renal, liver) biopsy is required. (no additional procedure will be performed.)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Transplantation (renal, liver) recipients who had undergone surgery at our institution, and are required for a graft biopsy.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Graft ICFA will be performed at immediate after, within 1 month, 6 months, and 1 year following organ transplantation. Since then, it will be performed annually. On the other hand, in case of graft dysfunction, it will be done properly.	—

Countries

Japan

Contacts

Public ContactTsukasa Nakamura

Kyoto Prefectural University of Medicine Department of Transplantation and Regenerative Surgery, Graduate School of Medical Science

tsukasa@koto.kpu-m.ac.jp075-251-5532

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026